Aldeyra Therapeutics
ALDX
#7315
Rank
ยฃ0.23 B
Marketcap
ยฃ4.03
Share price
-1.12%
Change (1 day)
-14.49%
Change (1 year)

P/E ratio for Aldeyra Therapeutics (ALDX)

P/E ratio as of October 2024 (TTM): -5.93

According to Aldeyra Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.93258. At the end of 2022 the company had a P/E ratio of -6.57.

P/E ratio history for Aldeyra Therapeutics from 2014 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-6.5775.64%
2021-3.74-38.97%
2020-6.13135.09%
2019-2.61-43.5%
2018-4.61-5.07%
2017-4.8651.62%
2016-3.20-33.85%
2015-4.8440.35%
2014-3.45

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
26.7-549.40%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.